Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i>
<b> </b>The emergence of carbapenem-resistant <i>Enterobacterales</i> (CRE) seriously limits treatment options for bacterial infections. Combined drugs are an effective strategy to treat these resistant strains. This study aimed to evaluate the synergistic effect of equol and...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/2/161 |
id |
doaj-6a710711e6b64687b8d5887afa09dcb8 |
---|---|
record_format |
Article |
spelling |
doaj-6a710711e6b64687b8d5887afa09dcb82021-02-06T00:01:24ZengMDPI AGAntibiotics2079-63822021-02-011016116110.3390/antibiotics10020161Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i>Hye-Rim Kim0Yong-Bin Eom1Department of Medical Sciences, Graduate School, Soonchunhyang University, Asan 31538, KoreaDepartment of Medical Sciences, Graduate School, Soonchunhyang University, Asan 31538, Korea<b> </b>The emergence of carbapenem-resistant <i>Enterobacterales</i> (CRE) seriously limits treatment options for bacterial infections. Combined drugs are an effective strategy to treat these resistant strains. This study aimed to evaluate the synergistic effect of equol and meropenem against carbapenem-resistant <i>Escherichia coli</i>.<b> </b>First, this study investigated the antibacterial activity of carbapenems on clinically isolated <i>E. coli</i> strains by analyzing the minimum inhibitory concentrations (MICs). The <i>E. coli</i> strains were all resistant to carbapenem antibiotics. Therefore, we confirmed the cause of carbapenem resistance by detecting <i>bla</i><sub>KPC</sub> and <i>bla</i><sub>OXA-48 </sub>among the carbapenemase genes using polymerase chain reaction (PCR) analysis. Checkerboard and time-kill analyses confirmed that equol restored the susceptibility of carbapenem-resistant <i>E. coli</i> to meropenem. Also, the transcription levels of specific carbapenemase genes in <i>E. coli</i> were significantly suppressed by equol. The study also evaluated the anti-virulence effects of equol on bacterial biofilm and motility through phenotypic and genotypic analyses. In conclusion, our results revealed that equol had a synergistic effect with meropenem on carbapenem-resistant <i>E. coli</i>.<b> </b>Therefore, this study suggests that equol is a promising antibiotic adjuvant that prevents the expression of carbapenemases and virulence factors in carbapenem-resistant <i>E. coli</i>.https://www.mdpi.com/2079-6382/10/2/161equolcarbapenem-resistant Escherichia colianti-bacterialanti-virulencesynergistic activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hye-Rim Kim Yong-Bin Eom |
spellingShingle |
Hye-Rim Kim Yong-Bin Eom Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> Antibiotics equol carbapenem-resistant Escherichia coli anti-bacterial anti-virulence synergistic activity |
author_facet |
Hye-Rim Kim Yong-Bin Eom |
author_sort |
Hye-Rim Kim |
title |
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> |
title_short |
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> |
title_full |
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> |
title_fullStr |
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> |
title_full_unstemmed |
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i> |
title_sort |
synergistic activity of equol and meropenem against carbapenem-resistant <i>escherichia coli</i> |
publisher |
MDPI AG |
series |
Antibiotics |
issn |
2079-6382 |
publishDate |
2021-02-01 |
description |
<b> </b>The emergence of carbapenem-resistant <i>Enterobacterales</i> (CRE) seriously limits treatment options for bacterial infections. Combined drugs are an effective strategy to treat these resistant strains. This study aimed to evaluate the synergistic effect of equol and meropenem against carbapenem-resistant <i>Escherichia coli</i>.<b> </b>First, this study investigated the antibacterial activity of carbapenems on clinically isolated <i>E. coli</i> strains by analyzing the minimum inhibitory concentrations (MICs). The <i>E. coli</i> strains were all resistant to carbapenem antibiotics. Therefore, we confirmed the cause of carbapenem resistance by detecting <i>bla</i><sub>KPC</sub> and <i>bla</i><sub>OXA-48 </sub>among the carbapenemase genes using polymerase chain reaction (PCR) analysis. Checkerboard and time-kill analyses confirmed that equol restored the susceptibility of carbapenem-resistant <i>E. coli</i> to meropenem. Also, the transcription levels of specific carbapenemase genes in <i>E. coli</i> were significantly suppressed by equol. The study also evaluated the anti-virulence effects of equol on bacterial biofilm and motility through phenotypic and genotypic analyses. In conclusion, our results revealed that equol had a synergistic effect with meropenem on carbapenem-resistant <i>E. coli</i>.<b> </b>Therefore, this study suggests that equol is a promising antibiotic adjuvant that prevents the expression of carbapenemases and virulence factors in carbapenem-resistant <i>E. coli</i>. |
topic |
equol carbapenem-resistant Escherichia coli anti-bacterial anti-virulence synergistic activity |
url |
https://www.mdpi.com/2079-6382/10/2/161 |
work_keys_str_mv |
AT hyerimkim synergisticactivityofequolandmeropenemagainstcarbapenemresistantiescherichiacolii AT yongbineom synergisticactivityofequolandmeropenemagainstcarbapenemresistantiescherichiacolii |
_version_ |
1724282733392297984 |